Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Jansen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 2, 2023
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian CancerSören Weidemann, Natalia Gorbokon, Maximilian Lennartz, et al.
Peerj|August 20, 2021
DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressivenessKristina Jansen, Franziska Büscheck, Katharina Moeller, et al.
Pathology, Research and Practice|October 30, 2021
DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samplesKristina Jansen, Nagina Farahi, Franziska Büscheck, et al.
Histology and Histopathology|June 1, 2022
DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancerKristina Jansen, Martina Kluth, Niclas C Blessin, et al.
Biomedicines|December 24, 2021
Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 TumoursJan Meiners, Kristina Jansen, Natalia Gorbokon, et al.
Biomedicines|April 30, 2021
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 TumorsSören Weidemann, Pauline Gagelmann, Natalia Gorbokon, et al.
Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 2, 2023
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian CancerSören Weidemann, Natalia Gorbokon, Maximilian Lennartz, et al.
Peerj|August 20, 2021
DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressivenessKristina Jansen, Franziska Büscheck, Katharina Moeller, et al.
Pathology, Research and Practice|October 30, 2021
DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samplesKristina Jansen, Nagina Farahi, Franziska Büscheck, et al.
Histology and Histopathology|June 1, 2022
DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancerKristina Jansen, Martina Kluth, Niclas C Blessin, et al.
Biomedicines|December 24, 2021
Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 TumoursJan Meiners, Kristina Jansen, Natalia Gorbokon, et al.
Biomedicines|April 30, 2021
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 TumorsSören Weidemann, Pauline Gagelmann, Natalia Gorbokon, et al.
Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
Pageof 2